Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Behavioural Phenomena of Family Firm Control Diversity and R&D Investment with Moderating Role CEO CompensationPsychology research and behavior management, 2023-01, Vol.16, p.397-417 [Peer Reviewed Journal]2023 Ghafoor et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Ghafoor et al. 2023 Ghafoor et al. ;ISSN: 1179-1578 ;EISSN: 1179-1578 ;DOI: 10.2147/PRBM.S383279 ;PMID: 36819007Full text available |
|
2 |
Material Type: Article
|
The Impact of Firm’s Unethical Behavior in Investment Decisions Among Young Investors in ChinaPsychology research and behavior management, 2022-01, Vol.15, p.3427-3443 [Peer Reviewed Journal]COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Tang et al. 2022 Tang et al. ;ISSN: 1179-1578 ;EISSN: 1179-1578 ;DOI: 10.2147/PRBM.S384377Full text available |
|
3 |
Material Type: Article
|
Behavior Towards R&D Investment of Family Firms CEOs: The Role of Psychological AttributePsychology research and behavior management, 2021-01, Vol.14, p.595-620 [Peer Reviewed Journal]2021 Zulfiqar et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Zulfiqar et al. 2021 Zulfiqar et al. ;ISSN: 1179-1578 ;EISSN: 1179-1578 ;DOI: 10.2147/PRBM.S306443 ;PMID: 34079397Full text available |
|
4 |
Material Type: Article
|
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosisClinical pharmacology: advances and applications, 2016-01, Vol.8 (Issue 1), p.9-13 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Tran et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1179-1438 ;EISSN: 1179-1438 ;DOI: 10.2147/CPAA.S98221 ;PMID: 26929672Full text available |